New insulin factory in Frankfurt: largest investment in Sanofi's history: The federal government, the state of Hesse, and the city of Frankfurt are ...
faz.net/aktuell/rhein-main/wirtschaft/neue-insulinfabrik-in-frankfurt-groesste-investition-in-der-sanofi-geschichte-accg-201601874.html
A New Era in Airway Disease Management: Advance your skills in managing and treating airway diseases with expert-led insights and clinical best practices.
medscape.org/advances/new-era-airway-disease-management-2025a1000j24
dpaq.de Oct 19
Sanofi launches €2bn project in Germany to boost EU insulin security: French pharmaceutical giant Sanofi has begun construction of a €2-billion ($2 ...
app.ekkow.com/1484900279221354982
STAT Oct 14
Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
statnews.com/pharmalot/2026/10/14/sanofi-settling-european-antitrust-probe-pharma-bro-shkreli/
Paid articlePaywall
Sanofi pays Regeneron up to $8B to expand immunology alliance: Regeneron will receive $1 billion upfront, with up to $7 billion more in milestones ...
dlvr.it/TVlJNj
During Rheumatoid Arthritis Awareness Month, explore education designed to help clinicians move beyond reactive care and support better long-term outcomes with ... Show more
Immunology Learning Nexus
Immunology Learning Nexus
Explore new content focused on recognizing uncontrolled moderate to severe asthma and identifying when referral or treatment escalation may be appropriate ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
htmedia.page.link Sep 30
Dividend income at risk? 8 stocks with inconsistent dividend payout: Indian Oil, Sanofi India, UTI AMC, and more
livemint.com/market/stock-market-news/dividend-income-at-risk-8-stocks-with-inconsistent-dividend-payout-indian-oil-sanofi-india-uti-amc-and-more-11790768058400.html
On this Health Awareness Day, recognize the role of glycemic control in diabetes and well-being. CGM improves detection of glucose fluctuations ... Show more
The CGM Toolbox
The CGM Toolbox
Next shock for Novo Nordisk shareholders: This is why the stock is plummeting: Novo Nordisk lowers growth expectations and warns of patent expirations ...
boerse-online.de/nachrichten/aktien/naechster-schock-fuer-novo-nordisk-aktionaere-darum-rauscht-die-aktie-ab-20409207.html
Novartis Just Cruised Past A Buy Point Amid Its Roche, Sanofi Rivalry: Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment ...
investors.com/news/technology/novartis-stock-multiple-sclerosis-treatment/
Take a global view of myasthenia gravis management. Compare evolving guideline recommendations, uncover practical clinical applications ... Show more
Autoimmune Disorders
Autoimmune Disorders
Gain practical strategies for managing CRSwNP beyond repeated oral steroid use. Learn how current evidence can help identify uncontrolled disease ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
Adani Ports, Radico, KFin among 6 top stock ideas for Aug by Motilal Oswal: Motilal Oswal Wealth Management Research Desk recommends 2 stocks each from the ...
business-standard.com/markets/news/adani-ports-radico-kfin-among-6-top-stock-ideas-for-aug-by-motilal-oswal-126080300065_1.html
STAT Aug 10
Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more
statnews.com/pharmalot/2026/08/10/sanofi-drug-shortage-jazz-pharma-deal/
Paid articlePaywall
Regeneron: Stock price turbocharges: Regeneron exceeded expectations with revenue of USD 4.29 billion and record profits at Dupixent and EYLEA ...
deraktionaer.de/artikel/aktien/megatrend-folger-regeneron-zuendet-den-kursturbo-20406138.html
Despite positive study data: Sanofi pulls the plug: Sanofi is ending the development of amlitelimab for moderate to severe atopic dermatitis ...
wallstreet-online.de/nachricht/21148256-strategische-neuausrichtung-trotz-positiver-studiendaten-sanofi-reissleine
Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit
investors.com/news/technology/sanofi-stock-dianthus-therapeutics-argenx-cidp-treatment/
Dividend stocks: Tata Tech, Sanofi Consumer, 20 others go ex-date next week: Upcoming Dividend stocks next week: Among the companies, Sanofi Consumer Healthcare ...
business-standard.com/markets/news/upcoming-dividend-stocks-tata-tech-sanofi-consumer-20-others-go-ex-date-next-week-126061200121_1.html
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
investors.com/news/technology/biotech-stock-avalo-therapeutics-hs-treatment/
Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO: Sanofi stock jumped Thursday after the French pharma beat first-quarter forecasts on the ...
investors.com/news/technology/sanofi-stock-sanofi-earnings-q1-2026/
From Merck to Sanofi: A Snake Pit Rather Than Retirement, Ms. Garijo?: After five years at the helm of Merck, Belén Garijo is stepping down. But instead of ...
faz.net/aktuell/wirtschaft/unternehmen/von-merck-zu-sanofi-lieber-schlangengrube-als-ruhestand-frau-garijo-200766615.html
Q4 result: Maruti Suzuki, Bandhan Bank, Castrol, and 42 more on April 28: Q4FY26 company results: Firms including AWL Agri Business, REC, Ceat, Dalmia Bharat ...
business-standard.com/companies/quarterly-results/q4-result-maruti-suzuki-bandhan-bank-castrol-and-42-more-on-april-28-126042800149_1.html
Stocks to Watch today: Coal India, Trent, Punjab & Sind Bk, Adani Total Gas: Stocks to Watch today, April 28, 2026: Coal India, Trent, City Union Bank ...
business-standard.com/markets/news/stocks-to-watch-today-coal-india-trent-punjab-sind-bk-adani-total-gas-126042800118_1.html
STAT Apr 24
Sanofi MS drug gets positive review in Europe following FDA: Today's biotech news includes news on Sanofi's MS drug, Regeneron's pricing deal with ...
statnews.com/2026/04/24/sanofi-ms-drug-europe-reveiew-regeneron-white-house/
Paid articlePaywall SAP, Sanofi and Nestlé gain ground: SAP, Nestlé and Sanofi exceed market expectations with strong quarterly results, despite geopolitical uncertainties ...
deraktionaer.de/artikel/indizes/sap-sanofi-und-nestl-ziehen-an-20399677.html
Gujarat Themis Biosyn zooms 14% on acquiring Sanofi's TB drug portfolio: The buying on the counter came after Gujarat Themis Biosyn signed an Asset Purchase ...
business-standard.com/markets/news/gujarat-themis-biosyn-zooms-14-percent-on-aacquiring-sanofi-s-tb-drug-portfolio-126042400508_1.html
European stocks to open in negative territory as oil prices gain : European stocks are expected to open in negative territory on Thursday as regional market ...
cnbc.com/2026/04/23/european-markets-stoxx-600-ftse-dax-cac-iran-latest-oil-prices.html
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker - Sanofi (NASDAQ:SNY)
benzinga.com/markets/biotech/26/04/51674881/from-lungs-to-nasal-polyps-sanofi-finds-success-with-2-in-1-inflammation-blocker
Fear of lobbyists? Government demands "vow of silence" on healthcare reform: Instead of cutting healthcare spending, the SPD wants to squeeze even more money out ...
berliner-zeitung.de/politik-gesellschaft/angst-vor-lobbyisten-regierung-fordert-schweigegeluebde-bei-gesundheitsreform-li.10023243
Paid articlePaywall
Africa: Single-Dose Treatment for Sleeping Sickness Receives Approval: Press Release - • Recommendation based on Phase II/III study demonstrating up to 96 per ...
allafrica.com/stories/202602270790.html
Stocks making the biggest moves midday: Tejas Networks, Vishal Megamart, RVNL, Netweb Technologies and more
financialexpress.com/market/stocks-making-the-biggest-moves-midday-tejas-networks-vishal-megamart-rvnl-netweb-technologies-and-more-4156578/
Stocks making the biggest moves midday: Waaree Energies, Tejas Network, Cholamandalam Investment and more
financialexpress.com/market/stocks-making-the-biggest-moves-midday-waaree-energies-tejas-network-cholamandalam-investment-and-more-4155531/
Sanofi Consumer up 14% on strong Q4; Sanofi India lags on weak earnings: Sanofi India shares fall 4% after Q4 profit drops 32%; Sanofi Consumer Healthcare India ...
business-standard.com/markets/news/sanofi-india-sanofi-consumer-healthcare-q4fy25-results-profit-revenue-126022600227_1.html
From Reliance Industries, IRFC, Tata Capital to KFin Technologies – Here are 10 stocks to watch today
financialexpress.com/market/from-reliance-industries-irfc-tata-capital-to-kfin-technologies-here-are-10-stocks-to-watch-today-4154892/
Sanofi's new CEO needs to fix drug pipeline and navigate Trump: Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors ...
reuters.com/business/healthcare-pharmaceuticals/sanofis-new-ceo-needs-fix-drug-pipeline-navigate-trump-2026-02-13/
Sanofi CEO is now Belén Garijo: Background to the personnel change unclear: The outgoing CEO of Merck is taking over at the French pharmaceutical giant Sanofi ...
faz.net/aktuell/wirtschaft/unternehmen/sanofi-chefin-ist-jetzt-belen-garijo-hintergruende-zum-personalwechsel-unklar-110836387.html
STAT Feb 13
Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
statnews.com/pharmalot/2026/02/12/trump-sanofi-abbvie-novo-lilly-gsk-teva-merck-bristol/
Paid articlePaywall Sanofi and Amgen: Is this approach facing its end? Shareholder tip benefits!: Amgen and Sanofi are struggling with side effects in OX40 programs for atopic ...
deraktionaer.de/artikel/pharma-biotech/sanofi-und-amgen-droht-diesem-ansatz-das-aus-aktionaer-tipp-profitiert-20394697.html
Paid articlePaywall STAT Feb 02
Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
statnews.com/pharmalot/2026/02/02/obesity-lilly-novo-sanofi-india-pfizer-fda/
Paid articlePaywallDrugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite: The drugmaker's full-year results didn't seem to move the needle for investors ...
cnbc.com/2026/01/29/roche-sanofi-earnings-pharma-drug-pipeline-obesity.html
STAT Jan 30
AstraZeneca looks to China for obesity drug candidates : Today's biotech news covers TrumpRx launch delayed, Sanofi shelving mRNA flu shots ...
statnews.com/2026/01/30/biotech-news-astrazeneca-china-obesity-drug-candidates/
Paid articlePaywall
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion: Dec 24 (Reuters) - Sanofi will buy U. vaccines company Dynavax Technologies for around $2.
finance.yahoo.com/news/sanofi-acquire-hepatitis-b-vaccine-114414352.html
Takeover bombshell on Christmas Eve: Billion-dollar deal in the pharmaceutical industry!
wallstreet-online.de/nachricht/20312846-ruhigen-festtage-uebernahme-hammer-heiligabend-milliardendeal-pharmabranche
Dividend guarantee Sanofi: Billion-dollar deal at Christmas: Sanofi buys Dynavax for $2.2 billion, strengthens vaccine business and expands pipeline.
deraktionaer.de/artikel/pharma-biotech/dividenden-garant-sanofi-milliarden-deal-an-weihnachten-20392675.html
Sanofi to pay Dren Bio up to $1.7 billion to develop autoimmune disease therapies
reuters.com/business/healthcare-pharmaceuticals/dren-bio-collaborate-with-sanofi-develop-autoimmune-disease-therapies-up-17-2025-12-15/
Sanofi, Regeneron’s Dupixent approved in Japan for children with asthma: Please provide the article text or its main content so I can generate the appropriate ...
seekingalpha.com/news/4534539-sanofi-regenerons-dupixent-approved-in-japan-for-children-with-asthma
Paid articlePaywall Ashish Kacholia’s Rs 566 crore bet: The ‘big whale’ stock that turned Rs 1 lakh into Rs 16 lakhs
financialexpress.com/market/stock-insights/ashish-kacholias-rs-566-crore-bet-the-big-whale-stock-that-turned-rs-1-lakh-into-rs-16-lakhs/4084365/
Sanofi: Setback for MS Drug - | Share Price Falls: A drug for the treatment of multiple sclerosis disappoints in studies. Investors apparently fear that this ...
handelsblatt.com/unternehmen/industrie/sanofi-rueckschlag-bei-ms-medikament-aktie-gibt-nach/100183945.html
Sanofi stock slumps after two setbacks on multiple-sclerosis drug: Shares of Sanofi slumped on Monday as the French drugmaker said a U.S. regulatory review of ...
marketwatch.com/story/sanofi-stock-slumps-after-two-setbacks-on-multiple-sclerosis-drug-c030de52
Paid articlePaywall Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation: Sanofi stock dropped Wednesday after French authorities raided the drugmaker's Paris ...
investors.com/news/technology/sanofi-stock-paris-raid-tax-fraud-investigation/
Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R: The American private equity firm has agreed to French government demands about protecting jobs ...
euronews.com/business/2024/10/21/france-takes-stake-in-sanofi-as-it-moves-ahead-with-cdr-deal
Key FactsSanofi to Sell Majority of Opella to US Fund
Oct 21, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: lemonde.fr
Summary created with AI assistance · Source: lemonde.fr
- Sanofi has entered exclusive negotiations with US fund CD&R to sell a majority stake in its over-the-counter subsidiary Opella.
- Despite concerns over the sale of the Doliprane painkiller, Sanofi intends to sell 50% of Opella, with the French government investing €100 to €150 million as a minority shareholder.
- The transaction is valued at approximately €16 billion and is expected to be finalized by the second quarter of 2025.
- The French government has set conditions to ensure compliance regarding production and employment in France.